درباره این اپیزود

انگلیسی
ایالات متحده آمریکا

یادداشت ها را نشان دهید 🔗

رونوشت 🔗

جستجوی اپیزودهای گذشته

اپیزودهای قبلی Digital Pathology Podcast را جستجو کن.

قسمت های دیگر در این پادکست

Send us Fan Mail Can a treatment decision depend on whether one pathologist sees 45% biomarker positivity and another sees 55%? Visual immunohistochemistry scoring helped establish precision oncology. But as targeted therapies become more sensitive to subtle biological differences, categorical scor…
Send us Fan Mail What does AI literacy actually look like for pathologists, researchers, and future clinicians? And how do you teach it in a way that is practical, not abstract? In this episode, I talk with Candice Chu, DVM, PhD about something I think a lot of people in digital pathology and compu…
Send us Fan Mail If AI is already being used across the drug development pipeline, why hasn’t its impact matched the investment? AI can help researchers review scientific literature, predict protein structures, prioritize molecules, assess toxicity, support clinical trials, and monitor adverse even…
Send us Fan Mail Are pathology foundation models actually ready for labs, or are they still stronger on paper than in practice? In this episode of DigiPath Digest #49, I unpack a timely review on pathology foundation models and ask the question that matters most to me: not just what these models ca…
Send us Fan Mail Is your digital pathology rollout moving so slowly that it’s creating a fragmented workflow instead of transforming the department? In this episode of the Digital Pathology Podcast, I speak with Dr. Syed Hoda, Director of Digital Pathology at NYU, about why gradual implementation m…
سلب مسئولیت: پادکست و آثار هنری تعبیه شده در این صفحه متعلق به Aleksandra Zuraw, DVM, PhD است که متعلق به صاحب آن است و به Listen Notes، Inc وابسته یا تایید نشده است.